Literature DB >> 6777025

Startle disease or hyperekplexia: further delineation of the syndrome.

F Andermann, D L Keene, E Andermann, L F Quesney.   

Abstract

Startle disease is an autosomal dominant disorder with two phenotypic expressions. In the major form, there is hypertonia in infancy, and later an insecure gait. The patients have falling attacks without unconsciousness and in these, they are often injured or suffer concussions. Episodes of shaking of the limbs lasting for several minutes and resembling generalized clonus or repetitive myoclonus occur. These are most often nocturnal and are also unaccompanied by loss of consciousness. the patients are hyperreflexic and show an increased incidence of associated neurological and electroencephalographic abnormalities. The minor form of startle disease is only manifested by excessive startle and this is inconstant. In infancy it is brought out by febrile illness and in adult life by emotional stress. Gastaut and Villeneuve postulated the existence of a sporadic form of hyperekplexia different from the disorder described by Suhren et al. Review of their report and comparison with the cases of Suhren et al, and our own patients leads us to believe that the sporadic and familial forms of startle disease are the same. The disorder is rare, probably misdiagnosed initially as spastic quadriplegia, and later as epilepsy. Clonazepam appears to be the treatment of choice and its effect is sustained.

Entities:  

Mesh:

Year:  1980        PMID: 6777025     DOI: 10.1093/brain/103.4.985

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  30 in total

1.  Hyperexplexia or stiff baby syndrome.

Authors:  C Tohier; J C Roze; A David; M F Veccierini; P Renaud; A Mouzard
Journal:  Arch Dis Child       Date:  1991-04       Impact factor: 3.791

2.  The effect of levetiracetam in startle disease.

Authors:  Gerhard J Luef; Wolfgang N Löscher
Journal:  J Neurol       Date:  2007-04-02       Impact factor: 4.849

3.  Hyperekplexia in two siblings.

Authors:  M L Kulkarni; B Kannan; Prakash Mathadh
Journal:  Indian J Pediatr       Date:  2006-12       Impact factor: 1.967

4.  Presynaptic glycine receptors as a potential therapeutic target for hyperekplexia disease.

Authors:  Wei Xiong; Shao-Rui Chen; Liming He; Kejun Cheng; Yi-Lin Zhao; Hong Chen; De-Pei Li; Gregg E Homanics; John Peever; Kenner C Rice; Ling-gang Wu; Hui-Lin Pan; Li Zhang
Journal:  Nat Neurosci       Date:  2014-01-05       Impact factor: 24.884

5.  Hyperekplexia masquerading as epilepsy.

Authors:  Jitendra Kumar Sahu; Anita Choudhary; Indranil Ghosh; Sheffali Gulati; Madhulika Kabra; Takeshi Taketani; Veena Kalra
Journal:  Indian J Pediatr       Date:  2011-01-09       Impact factor: 1.967

6.  A novel nonsense autosomal dominant mutation in the GLRA1 gene causing hyperekplexia.

Authors:  Ivan Milenkovic; Alexander Zimprich; Martin Gencik; Kirsten Platho-Elwischger; Stefan Seidel
Journal:  J Neural Transm (Vienna)       Date:  2018-09-04       Impact factor: 3.575

7.  Reflex seizures in Down syndrome.

Authors:  S M Pueschel; S Louis
Journal:  Childs Nerv Syst       Date:  1993-02       Impact factor: 1.475

8.  The glycinergic system in human startle disease: a genetic screening approach.

Authors:  Jeff S Davies; Seo-Kyung Chung; Rhys H Thomas; Angela Robinson; Carrie L Hammond; Jonathan G L Mullins; Eloisa Carta; Brian R Pearce; Kirsten Harvey; Robert J Harvey; Mark I Rees
Journal:  Front Mol Neurosci       Date:  2010-03-23       Impact factor: 5.639

9.  Stiff man syndrome: clinical and laboratory findings in eight patients.

Authors:  H M Meinck; K Ricker; P J Hülser; E Schmid; J Peiffer; M Solimena
Journal:  J Neurol       Date:  1994-01       Impact factor: 4.849

10.  Genetic and radiation hybrid mapping of the hyperekplexia region on chromosome 5q.

Authors:  S G Ryan; M J Dixon; M A Nigro; K A Kelts; O N Markand; J C Terry; R Shiang; J J Wasmuth; P O'Connell
Journal:  Am J Hum Genet       Date:  1992-12       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.